Resonant Capital Advisors’s Sanofi SNY Stock Holding History

Resonant Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Buy	+4,289	New	+$200K	0.01%	477

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Resonant Capital Advisors's SNY Position: Q1 2026 in Review

Resonant Capital Advisors opened a new position in Sanofi (SNY) in Q1 2026: 4,289 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #477 among its holdings.

738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Resonant Capital Advisors held 4,289 shares of Sanofi worth $207K as of Q1 2026.
Sanofi was a new Resonant Capital Advisors position in Q1 2026.
Sanofi made up 0.01% of Resonant Capital Advisors's portfolio in Q1 2026, its #477 holding.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Resonant Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.